Pharmaceutical Product Development, LLC (PPD) has created a dedicated unit combining its medical affairs research operations (MARO) team and Evidera, a provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of biopharmaceuticals. PPD acquired Evidera last year.   The new unit, retaining the Evidera name, will provide solutions, including modeling and simulation, interventional studies (including expanded access/compassionate use and extended access),...